Mesoblast Limited (MSB) Stock Statistics & Valuation Metrics

Mesoblast Limited has a market cap or net worth of AU$2.76B. The enterprise value is AU$3.52K.

Mesoblast Limited has 1,298,748,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesoblast Limited’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -7.43%.

The current PE Ratio of Mesoblast Limited is ―. Mesoblast Limited’s PEG ratio is 0.61.

In the last 12 months, Mesoblast Limited had revenue of 122.89M and earned -58.76M in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was -43.83M and capital expenditures -898.00K, giving a free cash flow of -44.73M billion.

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Mesoblast Limited upcoming earnings date is Mar 4, 2027, TBA (Confirmed).

Mesoblast Limited as a current ratio of 2.43, with Debt / Equity ratio of 22.40%

In the past 12 months, Mesoblast Limited has paid 626.46K in taxes.

Mesoblast Limited EV to EBITDA ratio is -42.08, with an EV/FCF ratio of -41.04.

Mesoblast Limited has AU$47.39M in cash and marketable securities with AU$127.33M in debt, giving a net cash position of -AU$79.94M billion.

Gross margin is 78.30%, with operating margin of -42.64%, and net profit margin of -47.82%.

The average price target for Mesoblast Limited is AU$3.64, which is 11.43% higher than the current price. The consensus rating is Strong Buy